Your browser doesn't support javascript.
loading
Show: 20 | 50 | 100
Results 1 - 7 de 7
Filter
1.
Am J Perinatol ; 37(5): 511-518, 2020 04.
Article in English | MEDLINE | ID: mdl-30895576

ABSTRACT

OBJECTIVE: This study aimed to report on Neonatal-Perinatal Medicine (NPM) fellows' views of self-preparedness upon starting postresidency training. STUDY DESIGN: We conducted a national survey of first-year NPM fellows in the United States. The validated survey had five major areas: professionalism, psychomotor ability, independence/graduated responsibility, clinical evaluation, and academia. Survey responses were analyzed using descriptive statistics, and the free-text answers were categorized. RESULTS: Of 228 potential first-year NPM fellows, 140 (61%) initially responded to the survey. Overall, the fellows perceived themselves positively in professionalism and independence/graduated responsibility domains. Marked variability was observed in perceived preparedness in psychomotor ability, with confidence in neonatal intubation and arterial line placement of 86 and 49%, respectively. Lack of confidence in performing neonatal intubation procedures correlates with lack of attempts. The majority (75%) of fellows reported being interested in academia, but less than half felt capable of writing an article. CONCLUSION: First-year NPM fellows identified deficiencies in the domains of psychomotor ability and academia. Residency and fellowship programs should partner to address these deficiencies.


Subject(s)
Clinical Competence , Internship and Residency , Neonatology/education , Perinatology/education , Education, Medical, Graduate , Fellowships and Scholarships , Female , Humans , Male , Surveys and Questionnaires , United States
2.
Pediatr Diabetes ; 19(3): 512-519, 2018 05.
Article in English | MEDLINE | ID: mdl-29094435

ABSTRACT

BACKGROUND: People with diabetes mellitus (DM) have increased infection risk. The healthcare utilization of pediatric and adolescent diabetic patients with infection is not well defined. This study evaluates the number of pediatric and adolescent patients with DM that seek medical treatment for infection management and assesses its socioeconomic impact. METHODS: A retrospective analysis was performed using the Pediatric Health Information System (PHIS) database on children and adolescents with DM who presented to the Emergency Department (ED) or were hospitalized for infection management from 2008 to 2014. The PHIS database collects admission, demographic, and economic data from 44 freestanding children's hospitals across the United States. RESULTS: In total, 123 599 diabetic patient encounters were identified (77% type 1 DM, 23% type 2 DM). ED visits and hospitalizations for type 1 DM and type 2 DM increased throughout the study period. Total charges for these encounters were greater than $250 million dollars per year and increased each year. Infection encounters make up more than 30% of that cost while accounting for only 14% of the visits. Respiratory infections were the most common type of infection followed by skin and soft tissue infections for both ED care and inpatient hospitalizations. Patients with infections had longer hospital length of stay and higher cost per day than those without infections. CONCLUSIONS: Children and adolescents with type 1 and type 2 DM commonly present to the ED and require hospitalization for infection evaluation and management. Encounters with infection make up a large proportion of a growing economic burden on the United States' healthcare system. As the prevalence of DM grows, this burden can be expected to become even more significant. Cost-effective strategies for the prevention of infection in pediatric patients with DM are needed.


Subject(s)
Diabetes Mellitus, Type 1/complications , Diabetes Mellitus, Type 2/complications , Emergency Service, Hospital/statistics & numerical data , Hospitalization/statistics & numerical data , Infections/etiology , Adolescent , Child , Female , Hospital Charges/statistics & numerical data , Hospitalization/economics , Hospitals, Pediatric/economics , Hospitals, Pediatric/statistics & numerical data , Humans , Infections/economics , Infections/epidemiology , Male , Retrospective Studies , United States/epidemiology
3.
Paediatr Int Child Health ; 37(4): 273-279, 2017 Nov.
Article in English | MEDLINE | ID: mdl-28978286

ABSTRACT

Urinary tract infections (UTI) are one of the most common and serious bacterial infections encountered by paediatricians and primary care physicians. Although the diagnosis and management of UTI appear simplistic, they remain among the most contentious issues in paediatrics. In part, UTI controversies stem from the absence of classic clinical symptoms, inappropriate urine specimen collection, modified urinary tract imaging recommendations, and diverse treatment and prevention strategies. Recently published guidelines and large clinical trials have attempted to clarify UTI diagnostic and management strategies. In this manuscript, we review the diagnosis and management of acute and recurrent UTI in the paediatric and adolescent populations.


Subject(s)
Disease Management , Urinary Tract Infections/diagnosis , Urinary Tract Infections/drug therapy , Adolescent , Anti-Bacterial Agents/therapeutic use , Antibiotic Prophylaxis , Bacteriological Techniques/methods , Child , Humans , Secondary Prevention , Specimen Handling/methods , Urinary Tract Infections/diagnostic imaging , Urinary Tract Infections/pathology
4.
Expert Rev Anti Infect Ther ; 13(1): 81-90, 2015 Jan.
Article in English | MEDLINE | ID: mdl-25421102

ABSTRACT

Urinary tract infection (UTI) is one of the most common bacterial infections encountered by pediatricians. Currently, the diagnosis and management of acute UTI and recurrent UTI in children remain controversial. Recently published guidelines and large clinical trials have attempted to clarify UTI diagnostic and management strategies. In this manuscript, we review the diagnosis and management of acute and recurrent UTI in the pediatric population.


Subject(s)
Urinary Tract Infections/diagnosis , Urinary Tract Infections/drug therapy , Acute Disease , Child , Child, Preschool , Humans , Infant , Infant, Newborn , Recurrence , Risk Factors , Urinary Tract Infections/epidemiology
5.
J Diabetes Complications ; 29(2): 192-5, 2015 Mar.
Article in English | MEDLINE | ID: mdl-25488325

ABSTRACT

AIMS: The objective of this study is to evaluate the number of diabetics that seek medical treatment in emergency departments or require hospitalization for infection management in the United States. This study also assesses the socioeconomic impact of inpatient infection management among diabetics. METHODS: We accessed the Healthcare Cost and Utilization Project's Nationwide Emergency Department Sample database and the Nationwide Inpatient Sample database to perform a retrospective analysis on diabetics presenting to the emergency department or hospitalized for infection management from 2006 to 2011. RESULTS: Emergency Department: Since 2006, nearly 10 million diabetics were annually evaluated in the emergency department. Infection was the primary reason for presentation in 10% of these visits. Among those visits, urinary tract infection was the most common infection, accounting for over 30% of emergency department encounters for infections. Other common infections included sepsis, skin and soft tissue infections, and pneumonia. Diabetics were more than twice as likely to be hospitalized for infection management than patients without diabetes. Hospitalization: Since 2006, nearly 6 million diabetics were annually hospitalized. 8-12% of these patients were hospitalized for infection management. In 2011, the inpatient care provided to patients with DM, and infection was responsible for over $48 billion dollars in aggregate hospital charges. CONCLUSIONS: Diabetics commonly present to the emergency department and require hospitalization for infection management. The care provided to diabetics for infection management has a large economic impact on the United States healthcare system. More efforts are needed to develop cost-effective strategies for the prevention of infection in patients with diabetes.


Subject(s)
Community-Acquired Infections/therapy , Diabetes Complications/therapy , Hospitalization , Patient Acceptance of Health Care , Cohort Studies , Community-Acquired Infections/complications , Community-Acquired Infections/economics , Community-Acquired Infections/epidemiology , Costs and Cost Analysis , Databases, Factual , Diabetes Complications/economics , Diabetes Complications/epidemiology , Emergency Service, Hospital , Health Care Costs/trends , Hospitalization/economics , Hospitalization/trends , Humans , Incidence , Insurance, Health , Length of Stay , Pneumonia/complications , Pneumonia/economics , Pneumonia/epidemiology , Pneumonia/therapy , Retrospective Studies , Sepsis/complications , Sepsis/economics , Sepsis/epidemiology , Sepsis/therapy , Skin Diseases, Infectious/complications , Skin Diseases, Infectious/economics , Skin Diseases, Infectious/epidemiology , Skin Diseases, Infectious/therapy , United States/epidemiology , United States Agency for Healthcare Research and Quality , Urinary Tract Infections/complications , Urinary Tract Infections/economics , Urinary Tract Infections/epidemiology , Urinary Tract Infections/therapy
6.
Clin Pediatr (Phila) ; 53(9): 831-8, 2014 Aug.
Article in English | MEDLINE | ID: mdl-24803633

ABSTRACT

Clinicians and patients continue to convey interest in personalized medicine. The objective of personalized medicine is to improve healthcare by tailoring disease prevention, diagnosis, and treatment strategies for individuals based on their unique clinical history and genetic composition. This article offers an overview of pharmacogenomics, discusses caveats specific to pharmacogenomics in pediatric populations, provides evidence-based recommendations for pediatric clinicians, and offers insight regarding the future role of pharmacogenomics testing in pediatric medicine. Reviews of the current literature and thoughtful discussions are presented regarding the pharmacogenomics of antidepressants, codeine and oncologic, asthma, and immunomodulatory pharmacotherapies.


Subject(s)
Mercaptopurine/pharmacology , Methotrexate/pharmacology , Pharmacogenetics , Antidepressive Agents/pharmacology , Asthma/drug therapy , Asthma/genetics , Child , Codeine/pharmacology , Cytochrome P-450 CYP2D6/drug effects , Humans , Immunologic Factors/pharmacology , Pediatrics , Polymorphism, Single Nucleotide , Tacrolimus/pharmacology
7.
BMC Pediatr ; 13: 187, 2013 Nov 16.
Article in English | MEDLINE | ID: mdl-24238149

ABSTRACT

BACKGROUND: Although the benefits of antipsychotic pharmacotherapy can be pronounced, many patients develop unwanted adverse effects including a variety of movement disorders. Compared with the traditional antipsychotics, the atypical antipsychotics have a decreased risk for associated movement disorders. Drug-induced movement disorders can occur, however, and the risk of adverse events can increase significantly when medications are abused. CASE PRESENTATION: We describe the case of a 13-year-old male who presented to an emergency department with acute movement disorders after nasal insufflation of crushed quetiapine. The patient was admitted and successfully treated for neuroleptic toxicity with intravenous antihistamine pharmacotherapy. His primary care provider and psychiatrist were notified of the abuse, quetiapine was discontinued, and the patient was discharged and referred to a drug and alcohol awareness and abuse program. CONCLUSIONS: The abuse of quetiapine has unfortunately become more common. This unique case report of acute movement disorders following nasal insufflation of quetiapine highlights the need for heightened vigilance when prescribing quetiapine and for increased awareness and education regarding medication-abuse.


Subject(s)
Akathisia, Drug-Induced/etiology , Antipsychotic Agents/adverse effects , Dibenzothiazepines/adverse effects , Dyskinesia, Drug-Induced/etiology , Myoclonus/chemically induced , Prescription Drug Misuse/adverse effects , Administration, Intranasal , Adolescent , Humans , Insufflation , Male , Quetiapine Fumarate
SELECTION OF CITATIONS
SEARCH DETAIL
...